News
-
-
-
COMMUNIQUÉ DE PRESSE
Monogram Technologies Reports Third Quarter 2024 Financial Results
Monogram Technologies Inc. closed an oversubscribed $13 million public offering to fund near-term commercialization milestones. Submitted a 510(k) premarket filing, received an AIR from the FDA, and secured a strategic collaboration for clinical trials with Shalby Limited -
-
-
COMMUNIQUÉ DE PRESSE
Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
Monogram Technologies Inc., an AI-driven robotics company specializing in orthopedic surgery, to attend LD Micro Main Event XVII Conference at Luxe Sunset Blvd Hotel, LA, on October 29 - 30, 2024
